TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancer. (Q51837762)
Jump to navigation
Jump to search
scientific article published on 9 July 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancer. |
scientific article published on 9 July 2014 |
Statements
1 reference
TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancer. (English)
1 reference
1 reference
1 reference
1 reference
Hartwig Huland
1 reference
Christina Koop
1 reference
Maria Christina Tsourlakis
1 reference
Jan Korbel
1 reference
Ali Attarchi Tehrani
1 reference
Corinna Wittmer
1 reference
Sarah Minner
1 reference
Guido Sauter
1 reference
Thorsten Schlomm
1 reference
Stefan Steurer
1 reference
Meike Adam
1 reference
Daniel Ospina-Klinck
1 reference
Christoph Plass
1 reference
Pascale Sophia Mayer
1 reference
Antje Krohn
1 reference
Ronald Simon
1 reference
Markus Graefen
1 reference
9 July 2014
1 reference
1 reference
66
1 reference
978-981
1 reference
6
1 reference
Identifiers
1 reference